MMP9 and cancer: The results show that ginsenoside Rg1 suppresses PMA-induced NF-κB DNA-binding activity and the phosphorylation of p65, a major component of NF-κB that is known to translocate to the nucleus following phosphorylation and transactivate the promoters of multiple cancer-related genes, including MMP-9.